Literature DB >> 6940623

Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL).

D R Miller, S Leikin, V Albo, H Sather, D Hammond.   

Abstract

The French-American-British (FAB) classification has been proposed as a useful and uniform method of defining morphologic subsets of acute leukaemias. As part of a prospective study designed to identify subsets of children with high risk of early relapse (CCG 141), submitted bone marrow slides from 765 of 883 patients entered on study were reviewed by two morphologists blinded as to prognostic factors and treatment regimen. L1, L2 and L3 acute lymphoblastic leukaemia (ALL) comprised 85.1%, 14.1% and 0.8%, respectively, of the total population. Children with greater than 25% L2 lymphoblasts had a significantly higher relapse rate and significantly poorer survival. Results of this study indicate that as a single variable, lymphoblast morphology is a very significant predictor of survival, haematologic remission, and complete continuous remission. Multivariate analyses show that lymphoblast morphology is again significant in determining duration of survival (P = 0.048), and is of borderline statistical significance (P = 0.089) in predicting length of complete continuous remission. The FAB classification, with minor modifications, is reproducible, useful, and prognostic in childhood ALL.

Entities:  

Mesh:

Year:  1981        PMID: 6940623

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  RT-PCR and real-time PCR analysis of E2A-PBX1, TEL-AML1, mBCR-ABL and MLL-AF4 fusion gene transcripts in de novo B-lineage acute lymphoblastic leukaemia patients in south India.

Authors:  Natarajan Sudhakar; Kamalalayam Raghavan Rajalekshmy; Thangarajan Rajkumar; Karunakaran Nirmala Nancy
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 2.  Routine immunophenotyping of acute leukaemias.

Authors:  H G Drexler; S M Gignac; J Minowada
Journal:  Blut       Date:  1988-12

3.  Extramedullary involvement in acute lymphoblastic leukemia and its relation to therapy.

Authors:  A Vani Rao; Kusum Verma; Kusum Kapila; V P Choudhry; H P Pati
Journal:  Indian J Pediatr       Date:  1991-07       Impact factor: 1.967

4.  The impact of variations in transcription of DICER and AGO2 on exacerbation of childhood B-cell lineage acute lymphoblastic leukaemia.

Authors:  Fatemeh Piroozian; Hoda Bagheri Varkiyani; Mohsen Koolivand; Maryam Ansari; Masoomeh Afsa; Ali AtashAbParvar; Kianoosh MalekZadeh
Journal:  Int J Exp Pathol       Date:  2019-05-15       Impact factor: 1.925

5.  Granular acute lymphoblastic leukaemia of childhood: a morphological phenomenon.

Authors:  P J Darbyshire; J S Lilleyman
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

6.  Cytological and immunological study of 139 patients with acute leukemia.

Authors:  J Minowada; G Mathé; M Barcos; M Ginsbourg; H Preisler; C Canon; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.

Authors:  J S Lilleyman; I M Hann; R F Stevens; O B Eden; S M Richards
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

8.  Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.

Authors:  F M Uckun; J H Kersey; K J Gajl-Peczalska; N A Heerema; A J Provisor; D Haag; G Gilchrist; C W Song; D C Arthur; J Roloff
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis.

Authors:  J L Gala; C Vermylen; G Cornu; A Ferrant; J L Michaux; M Philippe; P Martiat
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

10.  Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia.

Authors:  A Settin; M Al Haggar; T Al Dosoky; R Al Baz; N Abdelrazik; M Fouda; S Aref; Y Al-Tonbary
Journal:  Indian J Pediatr       Date:  2007-03       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.